These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

341 related items for PubMed ID: 30239168

  • 1. Adenocarcinoma of the esophagogastric junction and its background mucosal pathology: A comparative analysis according to Siewert classification in a Japanese cohort.
    Urabe M, Ushiku T, Shinozaki-Ushiku A, Iwasaki A, Yamazawa S, Yamashita H, Seto Y, Fukayama M.
    Cancer Med; 2018 Oct; 7(10):5145-5154. PubMed ID: 30239168
    [Abstract] [Full Text] [Related]

  • 2. Novel abdominal approach for dissection of advanced type II/III adenocarcinoma of the esophagogastric junction: a new surgical option.
    Hu C, Zhu HT, Xu ZY, Yu JF, Du YA, Huang L, Yu PF, Wang LJ, Cheng XD.
    J Int Med Res; 2019 Jan; 47(1):398-410. PubMed ID: 30296865
    [Abstract] [Full Text] [Related]

  • 3. Should Pyloric Lymph Nodes Be Dissected for Siewert Type II and III Adenocarcinoma of the Esophagogastric Junctions: Experience from a High-Volume Center in China.
    Cao H, Ooi M, Yu Z, Wang Q, Li Z, Lu Q, Wu Y.
    J Gastrointest Surg; 2019 Feb; 23(2):256-263. PubMed ID: 30334176
    [Abstract] [Full Text] [Related]

  • 4. Distribution of involved abdominal lymph nodes is correlated with the distance from the esophagogastric junction to the distal end of the tumor in Siewert type II tumors.
    Mine S, Kurokawa Y, Takeuchi H, Kishi K, Ito Y, Ohi M, Matsuda T, Hamakawa T, Hasegawa S, Yoshikawa T, Hiki N.
    Eur J Surg Oncol; 2015 Oct; 41(10):1348-53. PubMed ID: 26087995
    [Abstract] [Full Text] [Related]

  • 5. Is adenocarcinoma of the esophagogastric junction different between Japan and western countries? The incidence and clinicopathological features at a Japanese high-volume cancer center.
    Hasegawa S, Yoshikawa T, Cho H, Tsuburaya A, Kobayashi O.
    World J Surg; 2009 Jan; 33(1):95-103. PubMed ID: 18958523
    [Abstract] [Full Text] [Related]

  • 6. Different histological status of gastritis in superficial adenocarcinoma of the esophagogastric junction.
    Yamada M, Kushima R, Oda I, Mojtahed K, Nonaka S, Suzuki H, Yoshinaga S, Matsubara A, Taniguchi H, Sekine S, Saito Y, Shimoda T.
    Jpn J Clin Oncol; 2014 Jan; 44(1):65-71. PubMed ID: 24220802
    [Abstract] [Full Text] [Related]

  • 7. Comparison of the 8th UICC staging system for esophageal and gastric cancers in Siewert type II junctional adenocarcinomas.
    Karstens KF, Ghadban T, Sawez S, Konczalla L, Woestemeier A, Bachmann K, Uzunoglu FG, Tachezy M, Vettorazzi E, Izbicki JR, Reeh M.
    Eur J Surg Oncol; 2020 Apr; 46(4 Pt A):638-643. PubMed ID: 31879051
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Clinicopathological features and prognostic factors of adenocarcinoma of the esophagogastric junction according to Siewert classification: experiences at a single institution in Japan.
    Hosokawa Y, Kinoshita T, Konishi M, Takahashi S, Gotohda N, Kato Y, Daiko H, Nishimura M, Katsumata K, Sugiyama Y, Kinoshita T.
    Ann Surg Oncol; 2012 Feb; 19(2):677-83. PubMed ID: 21822549
    [Abstract] [Full Text] [Related]

  • 11. [Survival comparison of Siewert II adenocarcinoma of esophagogastric junction between transthoracic and transabdominal approaches:a joint data analysis of thoracic and gastrointestinal surgery].
    Yang S, Yuan Y, Hu H, Li R, Liu K, Zhang W, Yang K, Yang Y, Bai D, Chen X, Zhou Z, Chen L.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb 25; 22(2):132-142. PubMed ID: 30799535
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. CD147 and MMP-9 expressions in type II/III adenocarcinoma of esophagogastric junction and their clinicopathological significances.
    Huang L, Xu AM, Peng Q.
    Int J Clin Exp Pathol; 2015 Feb 25; 8(2):1929-37. PubMed ID: 25973085
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The prognostic relevance of parapyloric lymph node metastasis in Siewert type II/III adenocarcinoma of the esophagogastric junction.
    Wang JB, Lin MQ, Li P, Xie JW, Lin JX, Lu J, Chen QY, Cao LL, Lin M, Zheng CH, Huang CM.
    Eur J Surg Oncol; 2017 Dec 25; 43(12):2333-2340. PubMed ID: 28928013
    [Abstract] [Full Text] [Related]

  • 18. Can Clinical Stage in the 8th Edition of the Union for International Cancer Control TNM Classification Stratify the Prognosis of Patients Undergoing Curative Surgery for Siewert Type II/III Adenocarcinoma of the Esophagogastric Junction?
    Watanabe H, Hasegawa S, Kumazu Y, Hashimoto I, Komori K, Suematsu H, Kano K, Fujikawa H, Aoyama T, Yamada T, Yukawa N, Yoshikawa T, Rino Y, Saito A, Ogata T, Oshima T.
    In Vivo; 2023 Dec 25; 37(4):1790-1796. PubMed ID: 37369497
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Comparison of postoperative survival between early-onset and late-onset adenocarcinoma of esophagogastric junction: a population-based study.
    Chen L, Jin T, Fang Y, Wu G, Yuan Y.
    J Gastroenterol Hepatol; 2024 Jun 25; 39(6):1073-1081. PubMed ID: 38353050
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.